Asymchem Laboratories Tianjin Co Ltd
06821
Company Profile
Business description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Contact
No. 6 Dongting 3rd Street
Economic and Technological Development Zone
Tianjin300457
CHNT: +86 2266389560
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
10,617
Stocks News & Analysis
stocks
AI driving growth for ASX tech share
ASX tech share raises funds to facilitate customer AI spend.
stocks
OpenAI is going public as the worst value among its peers
Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks
Wide moat healthcare leader remains undervalued
ASX healthcare giant expected to see uptick in demand from emerging markets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,824.80 | 67.50 | 0.77% |
| CAC 40 | 8,288.20 | 88.91 | 1.08% |
| DAX 40 | 24,804.33 | 188.11 | 0.76% |
| Dow JONES (US) | 51,232.00 | 445.99 | 0.88% |
| FTSE 100 | 10,347.72 | 25.48 | -0.25% |
| HKSE | 24,565.90 | 91.16 | -0.37% |
| NASDAQ | 26,226.28 | 296.62 | 1.14% |
| Nikkei 225 | 65,416.63 | 1,392.03 | 2.17% |
| NZX 50 Index | 13,204.08 | 165.84 | 1.27% |
| S&P 500 | 7,475.98 | 70.25 | 0.95% |
| S&P/ASX 200 | 8,604.20 | 70.70 | 0.83% |
| SSE Composite Index | 4,010.03 | 50.69 | 1.28% |